In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa

被引：0
|
作者：
Zhu, Ying [1 ,2 ,3 ]
Findlay, Jacqueline [2 ,4 ]
Bouvier, Maxime [2 ,4 ]
Yang, Qiwen [1 ]
Xu, Yingchun [1 ]
Nordmann, Patrice [2 ,4 ]
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China
[2] Univ Fribourg, Fac Sci & Med, Med & Mol Microbiol, Chemin Musee 18, CH-1700 Fribourg, Switzerland
[3] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
[4] Univ Fribourg, Swiss Natl Reference Ctr Emerging Antibiot Resista, Fribourg, Switzerland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2024年 / 80卷 / 02期
关键词：
D O I：
10.1093/jac/dkae445
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：593 / 595
页数：3
相关论文
共 50 条
  • [41] In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii
    Hawser, Stephen P.
    Hackel, Meredith
    Person, Mary B.
    Higgins, Paul G.
    Seifert, Harald
    Dowzicky, Michael
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (03) : 289 - 290
  • [42] Responses of carbapenemase-producing and non-producing carbapenem-resistant Pseudomonas aeruginosa strains to meropenem revealed by quantitative tandem mass spectrometry proteomics
    Salva-Serra, Francisco
    Jaen-Luchoro, Daniel
    Marathe, Nachiket P.
    Adlerberth, Ingegerd
    Moore, Edward R. B.
    Karlsson, Roger
    FRONTIERS IN MICROBIOLOGY, 2023, 13
  • [43] Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae
    Gauthier, Lauraine
    Bonnin, Remy A.
    Dortet, Laurent
    Naas, Thierry
    PLOS ONE, 2017, 12 (02):
  • [44] Molecular Characterization of OXA-198 Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates
    Bonnin, Remy A.
    Bogaerts, Pierre
    Girlich, Delphine
    Huang, Te-Din
    Dortet, Laurent
    Glupczynski, Youri
    Naas, Thierry
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (06)
  • [45] P073: Outbreak of carbapenemase-producing Pseudomonas aeruginosa in a tertiary care hospital
    P Navarro
    M Cantero Caballero
    I Wijers
    I Cerón
    E Martinez de Albeniz
    P Rodriguez
    Antimicrobial Resistance and Infection Control, 2 (Suppl 1)
  • [46] Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods
    Akhi, Mohammad Taghi
    Khalili, Younes
    Ghotaslou, Reza
    Kafil, Hossein Samadi
    Yousefi, Saber
    Nagili, Behroz
    Goli, Hamid Reza
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (03) : 144 - 149
  • [47] Synergistic activities of meropenem double and triple combinations against carbapenemase-producing Enterobacteriaceae
    Fredborg, Marlene
    Sondergaard, Teis E.
    Wang, Mikala
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (04) : 355 - 360
  • [48] High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria
    Olalekan, Adesola
    Bader, Baris Kai
    Iwalokun, Bamidele
    Wolf, Sophia
    Lalremruata, Albert
    Dike, Adobi
    Mannie-Udoh, Morounke
    Lo Presti, Libera
    Liese, Jan
    Guther, Julia
    D'alvise, Paul
    Peter, Silke
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):
  • [49] Determining the Optimal Carbapenem MIC That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
    Tamma, Pranita D.
    Huang, Yanjie
    Opene, Belita N. A.
    Simner, Patricia J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6425 - 6429
  • [50] Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany
    Schaefer, Elena
    Malecki, Monika
    Tellez-Castillo, Carlos J.
    Pfennigwerth, Niels
    Marlinghaus, Lennart
    Higgins, Paul G.
    Mattner, Frauke
    Wendel, Andreas F.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2019, 8 (01)
12345